Immunoblots revealed a strong increase in p53 levels upon Brn3a inhibition, associated with increased p21, a cell cycle inhibitory protein and known p53 target gene in melanoma (Besch et al, 2007) (Fig 4A). Here, TP53 is linked to melanoma.